Article Details

Genentech's Phase III STARGLO Study Demonstrates Columvi Significantly Extends ...

Retrieved on: 2024-06-16 13:04:24

Tags for this article:

Click the tags to see associated articles and topics

Genentech's Phase III STARGLO Study Demonstrates Columvi Significantly Extends .... View article details on hiswai:

Excerpt

SOUTH SAN FRANCISCO, CA, USA I June 15, 2024 I Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today statistically ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo